Arch Therapeutics Inc (OTCPK:ARTH)
$ 0.85 -0.1 (-10.53%) Market Cap: 3.78 Mil Enterprise Value: 11.09 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 40/100

Arch Therapeutics Inc at Ladenburg Thalmann Virtual Healthcare Conference Transcript

Jul 13, 2021 / 04:00PM GMT
Release Date Price: $19.38 (-3.10%)
Michael Higgins
Ladenburg Thalmann & Company Inc. - Analyst

All right. Well, thank you, everyone, for joining us. My name is Michael Higgins, Managing Director, Senior Biotech Analyst here at Ladenburg Thalmann. Our next company to present is Arch Therapeutics. Joining us for this is Co-Founder, CEO, Terrence Norchi; as well as the recently joined CFO, Mike Abrams. I understand you guys have got some videos to show as well, so look forward to seeing that. And this is more of a fireside chat format, so I will be coming back in later and we will go through a few Q&As if that is good with you guys.

Terrence Norchi
Arch Therapeutics, Inc. - CEO

Sounds good. Thank you.

Mike Abrams
Arch Therapeutics, Inc. - CFO

Thank you.

Michael Higgins
Ladenburg Thalmann & Company Inc. - Analyst

All right, Terry, I will let you take it from here. Thank you, guys.

Terrence Norchi
Arch Therapeutics, Inc. - CEO

So thank you, Michael

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot